Keep up to date with NTD research from Canadian researchers. Check back soon for additional Canadian research updates.

Bolded names indicate Canadian researchers.

Boggild AK, Geduld J, Libman M, Yansouni CP, McCarthy AE, Hajek J, Ghesquiere W, Vincelette J, Kuhn S, Plourde PJ, Freedman DO, Kain KC. Illness in Canadian travellers and migrants from Brazil: CanTravNet surveillance data, 2013-2016. Can Commun Dis Rep. 2016 Aug 4;42(8):153-157.

Burgos LM, Farina J, Liendro MC, Saldarriaga C, Liprandi AS, Wyss F, Mendoza I, Baranchuk A. Neglected Tropical Diseases and Other Infectious Diseases Affecting the Heart. The NET-Heart Project: Rationale and Design. Global Heart. 2020;15(1):60. doi: 10.5334/gh.867.

Chappuis F, Alirol E, d’Acremont V, Bottieau E, Yansouni CP. Rapid diagnostic tests for non-malarial febrile illness in the tropics. Clin Microbiol Infect. 2013 May;19(5):422-31. doi: 10.1111/1469-0691.12154.

Herricks JR, Hotez PJ, Wanga V, Coffeng L, Haagsma JA, Stanaway J, Basanez MG, Buckle G, Budke C, Carabin H, Fèvre E, Fürst T, King CH, Murdoch ME, Ramaiah KD, Shepard DS, Stolk WA, Undurraga EA, Naghavi M, Murray CJJ. The global burden of disease study 2013: What does it mean for the NTDs? PLoS Negl Trop Dis 2007; 11(8): e0005424. doi 10.1371/journal.pntd.0005424.

Hotez PJ, Alvarado M, Basanez MG, Bollinger I, , Bourne R, Boussinesq M, Brooker SJ, Brown AS, Buckle G, Budke CM, Carabin H. et al. The global burden of disease study 2010: Interpretation and implications for the Neglected Tropical Diseases. PLoS Negl Trop Dis. 2014; 8(7): e2865. doi 10.1371/journal.pntd.0002865.

John CC, Carabin H, Montano SM, Bangira P, Zunt JR, Peterson PK. Global research priorities for infections that affect the nervous system. Nature. 2015; 527(7578): S178-86. doi: 10.1038/nature16033.

Mieras LF, Anand S, van Brakel WH, Hamilton HC, Kollmann KHM, Mackenzie C, Mason I, Wickenden A. Neglected Tropical Diseases, Cross-Cutting Issues Workshop, 4–6 February 2015, Utrecht, the Netherlands: Meeting report. International Health. 2016; 8(suppl_1): i7–i11. doi: 10.1093/inthealth/ihw001

Phillips K, Kohler J, Pennefather P, Thorsteinsdottir H, Wong J. Canada’s neglected tropical disease research network: who’s in the core—who’s on the periphery? PLoS Negl Trop Dis. 2013; 7(12): e2568.

Polman K, Becker SL, Alirol E, Bhatta NK, Bhattarai NR, Bottieau E, Bratschi MW, Burza S, Coulibaly JT, Doumbia MN, Horié NS, Jacobs J, Khanal B, Landouré A, Mahendradhata Y, Meheus F, Mertens P, Meyanti F, Murhandarwati EH, N’Goran EK, Peeling RW, Ravinetto R, Rijal S, Sacko M, Saye R, Schneeberger PHH, Schurmans C, Silué KD, Thobari JA, Traoré MS, van Lieshout L, van Loen H, Verdonck K, von Müller L, Yansouni CP, Yao JA, Yao PK, Yap P, Boelaert M, Chappuis F, and Utzinger J. erratum to: Diagnosis of neglected tropical diseases among patients with persistent digestive disorders (diarrhoea and/or abdominal pain ≥14 days): A multi-country, prospective, non-experimental case–control study. BMC Infectious Diseases. 2015; 15:499. doi: 10.1186/s12879-015-1160-0.

Sodahlon Y, Ross DA, McPhillips-Tangum C, Lawrence J, Taylor R, McFarland DA, Krentel A, et al. Building country capacity to sustain NTD programs and progress: A call to action. PLoS Negl Trop Dis. 2020, 14(10): e0008565. doi: 10.1371/journal.pntd.0008565.

Torgerson PR, Devleesschauwer B, Praet N, Speybroeck N, Willingham AL, Kasuga F, Rokni MB, Zhou X-N, Fevre EM, Sripa B, Furst T, Budke CM, Carabin H, Kirk MD, Angulo FJ, Havelaar A, de Silva N. World Health Organization estimates of the global and regional disease burden of 11 foodborne parasitic diseases, 2010: A data synthesis. PLoS Med 2015; 12(12): e1001920. doi 10.1371/journal.pmed.1001920.

Vande Velde F, Longva J, Overgaard HJ, Bastien S. Identifying nudge strategies for behavior-based prevention and control of neglected tropical diseases. JBI Evidence Synthesis: July 23, 2020. doi: 10.11124/JBIES-20-00042.

Yansouni CP, Bottieau E, Lutumba P, Winkler AS, Lynen L, Büscher P, Jacobs J, Gillet P, Lejon V, Alirol E, Polman K, Utzinger J, Miles MA, Peeling RW, Muyembe JJ, Chappuis F, Boelaert M. Rapid diagnostic tests for neurological infections in central Africa. Lancet Infect Dis. 2013 Jun;13(6):546-58. doi: 10.1016/S1473-3099(13)70004-5.

Yegorov S, Joag V, Galiwango RM, Good SV, Okech B & Kaul R. Impact of endemic infections on HIV susceptibility in sub-Saharan Africa. Tropical Diseases, Travel Medicine and Vaccines. 2019; 5(22).

Acquatella H, Asch FM, Barbosa MM, Barros M, Bern C, Cavalcante JL, Echeverria Correa LE, Lima J, Marcus R, Marin-Neto JA, Migliore R, Milei J, Morillo CA, Nunes MCP, Campos Vieira ML, Viotti R. Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the American Society of Echocardiography in collaboration with the InterAmerican Association of Echocardiography (ECOSIAC) and the Cardiovascular Imaging Department of the Brazilian Society of Cardiology (DIC-SBC). J Am Soc Echocardiogr. 2018 Jan;31(1):3-25. doi: 10.1016/j.echo.2017.10.019.

Carmo AAL, de Sousa MR, Agudelo JF, Boersma E, Rocha MOC, Ribeiro ALP, Morillo CA. Implantable cardioverter-defibrillator in Chagas heart disease: a systematic review and meta-analysis of observational studies. Int J Cardiol. 2018 Sep 15;267:88-93. doi: 10.1016/j.ijcard.2018.05.091.

Ciapponi A, Barreira F, Perelli L, Bardach A, Gascón J, Molina I, Morillo C, et al. Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysis. PLOS Negl Trop Dis. 2020. 14(8): e0008529. doi: 10.1371/journal.pntd.0008529.

Fearon MA, Scalia V, Huang M, Dines I, Ndao M, Lagacé-Wiens P. A case of vertical transmission of Chagas disease contracted via blood transfusion in Canada. Can J Infect Dis Med Microbiol. 2013 Spring;24(1):32-4. PMID: 24421790.

Mongeau-Martin G, Ndao M, Libman M, Delage G, Ward BJ. A family cluster of Chagas disease detected through selective screening of blood donors: A case report and brief review. Can J Infect Dis Med Microbiol. 2015 May-Jun;26(3):157-61. PMID: 26236358.

Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A, Rosas F, Villena E et al. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med. 2015 Oct;373(14): 1295-1306. doi: 10.1056/NEJMoa1507574.

Morillo CA, Waskin H, Sosa-Estani S, Del Carmen Bangher M, Cuneo C, Milesi R et al. Benznidazole and Posaconazole in eliminating parasites in asymptomatic T. Cruzi carriers: The STOP-CHAGAS Trial. J Am Coll Cardiol. 2017 Feb;69(8):939-947. doi: 10.1016/j.jacc.2016.12.023.

Ndao M, Beaulieu C, Black WC, Isabel E, Vasquez-Camargo F, Nath-Chowdhury M, Massé F, Mellon C, Methot N, Nicoll-Griffith DA. Reversible cysteine protease inhibitors show promise for a Chagas disease cure. Antimicrob Agents Chemother. 2014;58(2):1167-78. doi: 10.1128/AAC.01855-13.

Nunes MCP, Beaton A, Acquatella H, Bern C, Bolger AF, Echeverría LE, Dutra WO, Gascon J, Morillo CA, Oliveira-Filho J, Ribeiro ALP, Marin-Neto, JA and on behalf of the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Stroke Council. Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association. 2018 August; 138 (12):e169–e209. doi: 10.1161/CIR.0000000000000599.

Plourde PJ, Kadkhoda K, Ndao M. Congenitally transmitted Chagas disease in Canada: a family cluster. CMAJ. 2017 Dec 4;189(48):E1489-E1492. doi: 10.1503/cmaj.170648

Rojas LZ, Glisic M, Pletsch-Borba L, Echeverría LE, Bramer WM, Bano A, Stringa N, Zaciragic A, Kraja B, Asllanaj E, Chowdhury R, Morillo CA, Rueda-Ochoa OL, Franco OH, Muka T. Electrocardiographic abnormalities in Chagas disease in the general population: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2018 Jun 13;12(6):e0006567. doi: 10.1371/journal.pntd.0006567.

Ruiz-Lancheros E, Rasoolizadeh A, Chatelain E, Garcia-Bournissen F, Moroni S, Moscatelli G, Altcheh J, Ndao M. Validation of apolipoprotein A-1 and fibronectin fragments as markers of parasitological cure for congenital Chagas Disease in children treated with benznidazole. Open Forum Infect Dis. 2018 Nov 1;5(11):ofy236. doi: 10.1093/ofid/ofy236.

Schmidt A, Dias Romano MM, Marin-Neto JA, Rao-Melacini P, Rassi A Jr, Mattos A, Avezum Á Jr, Villena E, Sosa-Estani S, Bonilla R, Yusuf S, Morillo CA, Maciel BC; BENEFIT Investigators. Effects of Trypanocidal treatment on echocardiographic parameters in Chagas cardiomyopathy and prognostic value of Wall Motion Score Index: A BENEFIT trial echocardiographic substudy. J Am Soc Echocardiogr. 2018 Nov 9. pii: S0894-7317(18)30504-2. doi: 10.1016/j.echo.2018.09.006.

Velasco A, Morillo CA. Chagas heart disease: A contemporary review. J Nucl Cardiol. 2018 Jul 18. doi: 10.1007/s12350-018-1361-1.

Arévalo-Cortés A, Mejia-Jaramillo AM, Granada Y, Coatsworth H, Lowenberger C, Triana-Chavez O. The Midgut Microbiota of Colombian Aedes aegypti Populations with Different Levels of Resistance to the Insecticide Lambda-cyhalothrin. Insects. 2020; 11, 584. doi: 10.3390/insects11090584.

Baker T, Wolfson DB. Evaluating Uncertainty in Dengue Seroprevalence in the Absence of a Gold Standard Diagnostic Test. McGill Journal of Medicine, 2020.

Carabali M, Pérez D, Degroote S, Reyes A, Kaufman JS, Ridde V. Towards a better integration of social sciences in arbovirus research and decision-making: an experience from scientific collaboration between Cuban and Quebec institutions. Global Health Promotion. 2020.

Charette M, Berrang-Ford L, Llanos Cuentas EA, Cárcamo C, Kulkarni MA. What caused the 2012 dengue outbreak in Pucallpa, Peru? A socio-ecological autopsy. Social Science and Medicine. 2017; 174: 122-132. doi 10.1016/j.socscimed.2016.12.010.

Dickin SK, Schuster-Wallace CJ. Assessing changing vulnerability to dengue in northeastern Brazil using a water-associated disease index approach. Global Environmental Change. 2014; 29:155-164. doi 10.1016/j.gloenvcha.2014.09.007.

Dickin SK, Schuster-Wallace CJ, Elliott SJ. Developing a vulnerability mapping methodology: applying the water-associated disease index to dengue in Malaysia. PLOS ONE. 2013; 8(5): e63584. doi: 10.1371/journal.pone.0063584.

Dickin SK, Schuster-Wallace CJ, Elliott SJ. Mosquitoes and vulnerable spaces: mapping local knowledge of sites for dengue control in Seremban and Putrajaya Malaysia. Applied Geography. 2014; 46:71–79 doi: 10.1016/j.apgeog.2013.11.003.

Durant AC, Donini A. Development of Aedes aegypti (Diptera: Culicidae) mosquito larvae in high ammonia sewage in septic tanks causes alterations in ammonia excretion, ammonia transporter expression, and osmoregulation. Sci Rep 9, 19028 (2019). doi: 10.1038/s41598-019-54413-6.

Fullerton LM, Dickin SK, Schuster-Wallace CJ. Mapping global vulnerability to dengue using the water associated disease Index. 2014. United Nations University.

Hébert C, Dagenais C, McSween-Cadieux E, Ridde V. Video as a public health knowledge transfer tool in Burkina Faso: A mixed evaluation comparing three narrative genres, PLoS Negl Trop Dis. 2020; 14(6): e0008305. doi: 10.1371/journal.pntd.0008305.

Homenauth E, Kajeguka D, Kulkarni MA. Principal component analysis of socioeconomic factors and their association with malaria and arbovirus risk in Tanzania: A sensitivity analysis. Journal of Epidemiology & Community Health. 2017; 71(11): 1046-1051. doi 10.1136/jech-2017-209119.

Hooshyar M, Wagner CE, et al. Cyclic epidemics and extreme outbreaks induced by hydro-climatic variability and memory. Journal of the Royal Society Interface. 2020; 17(171). doi: 10.1098/rsif.2020.0521.

Kajeguka DC, Desrochers R, Mwangi R, Mgabo MR, Alifrangis M, Kavishe RA, Mosha FW, Kulkarni MA. Knowledge and practice regarding dengue and chikungunya: A cross sectional study among healthcare workers and community in northern Tanzania. Tropical Medicine & International Health. 2017; 22(5): 583-593. doi 10.1111/tmi.12863

Kajeguka D, Kaaya R, Desrochers R, Iranpour M, Kavishe RA, Mwakalinga S, Schiøler KL, Alifrangis M, Lindsay LR, Dibernardo A, Mosha FW, Kulkarni MA. Mapping clusters of chikungunya and dengue transmission in Northeastern Tanzania using disease exposure and vector data. Tanzania Journal of Health Research. 2017; 19(4): 1-12. doi: 10.4314/thrb.v19i4.1.

Misyura L, Grieco Guardian E, Durant AC, Donini A. A comparison of aquaporin expression in mosquito larvae (Aedes aegypti) that develop in hypo-osmotic freshwater and iso-osmotic brackish water. PLOS ONE. 2020. 15(8): e0234892. doi: 10.1371/journal.pone.0234892.

Mulligan K, Elliott SJ, Schuster-Wallace CJ. Global public health policy transfer and dengue fever in Putrajaya, Malaysia: a critical discourse analysis. Critical Public Health. 2012b; 22(4):407-418 doi: 10.1080/09581596.2012.659722.

Mulligan K, Elliott SJ, Schuster-Wallace CJ. The place of health and the health of place: dengue fever and urban governance in Putrajaya, Malaysia. Health and Place. 2012a; 18(3):613-620 doi: 10.1016/j.healthplace.2012.01.001.

Poole-Smith BK, Gilbert A, Gonzalez AL, Beltran M, Tomashek KM, Ward BJ, Hunsperger EA, Ndao M. Discovery and characterization of potential prognostic biomarkers for dengue hemorrhagic fever. Am J Trop Med Hyg. 2014 Dec;91(6):1218-26. doi: 10.4269/ajtmh.14-0193. Epub 2014 Oct 27.

Yuan X, Garg S, de Haan K, Fellouse FA, Gopalsamy A, Tykvart J, Sidhu SS, Varma MM, Pal P, Hillan EM, Dou JJ, Aitchison JS. Bead-based multiplex detection of dengue biomarkers in a portable imaging device. Biomed. Opt. Express. 2020. 11, 6154-6167. doi: 10.1364/BOE.403803.

Zhao N, Charland K, Carabali M, Nsoesie EO, Maheu-Giroux M, Rees E, Yuan M, Garcia Balaguera C, Jaramillo Ramirez G, Zinszer K. Machine learning and dengue forecasting: Comparing random forests and artificial neural networks for predicting dengue burden at national and sub-national scales in Colombia. PLOS Neglected Tropical Diseases 2020, 14(9): e0008056. doi: 10.1371/journal.pntd.0008056.

Carabin H, Balsera-Rodriguez FJ, Rebollar-Saenz J, Benner CT, Benito A, Fernandez-Crespo JC, Carmena D. Cystic echinococcosis in the province of Alava, North Spain: The monetary burden of a disease no longer under surveillance. PLoS Negl Trop Dis 2014; 8(8): e3069. doi 10.1371/journal.pntd.0003069.

Alejandro Ortiz HI, Farina JM, Saldarriaga C, Mendoza I, Sosa Liprandi A, Wyss F, Burgos LM, Alexander B, Baranchuk A. Human African Trypanosomiasis & Heart, Expert Review of Cardiovascular Therapy. 2020. doi: 10.1080/14779072.2020.1828066.

Boelaert M, Mukendi D, Bottieau E, Kalo Lilo JR, Verdonck K, Minikulu L, Barbé B, Gillet P, Yansouni CP, Chappuis F, Lutumba P. A Phase III diagnostic accuracy study of a rapid diagnostic test for diagnosis of second-stage human African trypanosomiasis in the Democratic Republic of the Congo. EBioMedicine. 2018 Jan;27:11-17. doi: 10.1016/j.ebiom.2017.10.032.

André S, Rodrigues V, Picard M, Silvestre R, Estaquier J. Non-human primates and Leishmania immunity. Cytokine: X. 2020 Dec; 4(2):100038. doi: 10.1016/j.cytox.2020.100038.

André S, Rodrigues V, Pemberton S, Laforge M, Fortier Y, Cordeiro-da-Silva A, MacDougall J, Estaquier J. Antileishmanial Drugs Modulate IL-12 Expression and Inflammasome Activation in Primary Human Cells. The Journal of Immunology April 1, 2020, 204 (7) 1869-1880; doi: 10.4049/jimmunol.1900590

Atayde VD, da Silva Lira Filho A, Chaparro V. et al. Exploitation of the Leishmania exosomal pathway by Leishmania RNA virus 1. Nat Microbiol 2019, 4, 714–723. doi:10.1038/s41564-018-0352-y.

Atayde VD, Hassani K, da Silva Lira Filho A, Borges A, Adhikari A, Martel C, Olivier M. Leishmania exosomes and other virulence factors: Impact on innate immune response and macrophage functions. Cellular Immunology. 2016. vol 309. doi: 1016/j.cellimm.2016.07.013.

Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, Carvalho E, Ephros M, Jeronimo S, Magill A. Diagnosis and treatment of Leishmaniasis: Clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Am J Trop Med Hyg. 2017 Jan 11;96(1):24-45. doi: 10.4269/ajtmh.16-84256.

Bodhale N, Ohms M, Ferreira C, Mesquita I, Mukherjee A, André S, Sakar A, Estaquier J et al. Cytokines and metabolic regulation: a framework of bidirectional influences affecting Leishmania infection. Cytokine. 2020 Sept, 155267. doi: 10.1016/j.cyto.2020.155267.

Boggild A, Caumes E, Grobusch M, Schwartz E, Hynes N, Libman M, Connor B, Chakrabarti S, Parola P, Keystone JS, Nash T, Showler A, Schunk M, Asgeirsson H, Hamer D, Kain K. Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis. Journal of Travel Medicine. 2019. Volume 26, Issue 8. doi: 10.1093/jtm/taz055.

Cuddihy G, Wasan EK, Yunyun D, Wasan KM. The development of oral Amphotericin B to treat systemic fungal and parasitic infections: has the myth finally been realized? Pharmaceutics. 2019 Mar; 11(3):99. doi: 10.3390/pharmaceutics11030099.

Diro E, Yansouni CP, Takele Y, Mengesha B, Lynen L, Hailu A, van Griensven J, Boelaert M, Büscher P. Diagnosis of visceral leishmaniasis using peripheral blood microscopy in Ethiopia: A prospective phase-III study of the diagnostic performance of different concentration techniques compared to tissue aspiration. Am J Trop Med Hyg. 2017 Jan 11;96(1):190-196. doi: 10.4269/ajtmh.16-0362.

Dong G, Filho Alonso L, Olivier M. Modulation of host-pathogen communication by extracellular vesicles (EVs) of the protozoan parasite Leishmania. Frontiers in Cellular and Infection Microbiology. 2019 (9). doi:10.3389/fcimb.2019.00100.

Douanne N, Dong G, Douanne M, Olivier M, Fernandez-Prada. Unravelling the proteomic signature of extracellular vesicles released by drug-resistant Leishmania infantum parasites. PLOS Neglected Tropical Diseases 2020 14(7): e0008439. 10.1371/journal.pntd.0008439.

Ferreira C, Mesquita I, Barbosa AM, Osório NS, Torrado E, Beauparlant C-J, Droit A, Cunha C, Carvalho A, Saha B, Estaquier J, et al. Glutamine supplementation improves the efficacy of miltefosine treatment for visceral leishmaniasis. PLOS Neglected Tropical Diseases. 2020 14(3): e0008125. doi: 10.1371/journal.pntd.0008125.

Hnik P, Wasan EK, Wasan KM. Safety, tolerability, and pharmacokinetics of a novel oral amphotericin B formulation (iCo-019) following single-dose administration to healthy human subjects: An alternative approach to parenteral amphotericin B administration. Antimicrobial Agents and Chemotherapy. 2020 Jul. doi: 10.1128/AAC.01450-20.

Kariyawasam R, Lau R, Valencia B, Llanos-Cuentas A, Boggild A. Leishmania RNA Virus 1 (LRV-1) in Leishmania (Viannia) braziliensis Isolates from Peru: A Description of Demographic and Clinical Correlates. Am J Trop Med Hyg. 2020 Feb;102(2):280-285. doi: 10.4269/ajtmh.19-0147.

Kariyawasam R, Challa P, Lau R, Boggild A. Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform. BMC Infect Dis 19, 593 2019. doi: 10.1186/s12879-019-4237-3.

Kiessling, S., Dubeau-Laramée, G., Ohm, H. et al. The circadian clock in immune cells controls the magnitude of Leishmania parasite infection. Sci Rep 7, 10892. 2017. doi: 10.1038/s41598-017-11297-8.

Mou Z, Li J, Boussoffara T, Kishi H, Hamana H, Ezzati P, Hu C, Yi W, Liu D, Khadem F, Okwor I, Jia P, Shitaoka K, Wang S, Ndao M, Petersen C, Chen J, Rafati S, Louzir H, Muraguchi A, Wilkins JA, Uzonna JE. Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4+ T cells. Sci Transl Med. 2015 Oct;7(310):310ra167. doi: 10.1126/scitranslmed.aac5477.

Olivier M, Fernandez-Prada C, Leishmania and its exosomal pathway: a novel direction for vaccine development. Future Microbiology 2019 14:7, 559-561. doi: 10.2217/fmb-2019-0087.

Olivier M, Menendez Minguez A, Fernandez-Prada C. Leishmania Viannia guyanensis. Trends in parasitology, 2019. doi: 10.1016/

Ruoti M, Oddone R, Lampert N, Orué E, Miles M, Alexander N, Rehman A, Njord R, Shu S, Brice S, Sinclair B, Krentel A. Mucocutaneous leishmaniasis: knowledge, attitudes, and practices among Paraguayan communities, patients, and health professionals. J Trop Med. 2013. doi: 10.1155/2013/538629.

Vucetic A., Filho A.D.S.L., Dong G., Olivier M. (2020) Isolation of extracellular vesicles from Leishmania spp.. in: Michels P., Ginger M., Zilberstein D. (eds) Trypanosomatids. Methods in Molecular Biology. 2020. vol 2116. Humana, New York, NY: doi: 0.1007/978-1-0716-0294-2_33.

Wasan, K. Development of novel oral formulation to treat systemic fungal infections. News Release (23 March 2020) for an article in Current Pharmaceutical Design.

Zhang WW, Ghosh AK, Mohamath R, Whittle J, Picone A, Lypaczewski P, Ndao M, Howard RF, Das P, Reed SG, Matlashewski G. Development of a sandwich ELISA to detect Leishmania 40S ribosomal protein S12 antigen from blood samples of visceral leishmaniasis patients. BMC Infect Dis. 2018 Oct 3;18(1):500. doi: 10.1186/s12879-018-3420-2.

Faust L, Klowak M, MacRae C, Kopalakrishnan S, Showler AJ, Boggild AK. Ofloxacin-Containing Multidrug Therapy in Ambulatory Leprosy Patients: A Case Series. Journal of Cutaneous Medicine and Surgery. September 2020. doi: 10.1177/1203475420952437.

Bratschi MW, Steinmann P, Wickenden A, et al. Current knowledge on Mycobacterium leprae transmission: a systematic literature review. Leprosy review. 2015; 86 (2) : 142-55.

Mensah-Awere D, Bratschi MW, Steinmann P, et al. Symposium Report : Developing Strategies to Block the Transmission of Leprosy. Leprosy review. 2015; 86 (2) : 156-64.

Krentel A, Damayanti R, Titaley C, Suharno N, Bradley M, Lynam T. Improving overage and compliance in mass drug administration for the elimination of LF in two ‘endgame’ districts in Indonesia using micronarrative surveys. PLoS Negl Trop Dis. 2016;10(11). doi: 10.1371/journal.pntd.0005027.

Bogus J, Gankpala L, Fischer K, Krentel A, Weil G, Fischer P, Kollie K, Bolay F (2015). Community attitudes toward mass drug administration for control and elimination of neglected tropical diseases after the 2014 outbreak of ebola virus disease in Lofa County, Liberia. Am J Trop Med Hyg. 2015;94(3). doi: 10.4269/ajtmh.15-0591.

Krentel A, Fische, P, Weil G. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. PLoS Negl Trop Dis. 2013;7(11). doi: 10.1371/journal.pntd.0002447.

Belkin A, Summerbell RC, Krajden S, Scott J. The type isolate of a rare Phaeoacremonium species as a cause of human eumycetoma. Medical Mycology Case Reports. 2020. vol 30:5-7. doi: 10.1016/j.mmcr.2020.08.002.

Gautret P, Angelo KM, Asgeirsson H, Lalloo DG, Shaw M, Schwartz E, Libman M, Kain KC, Piyaphanee W, Murphy H, Leder K, Vincelette J, Jensenius M, Waggoner J, Leung D, Borwein S, Blumberg L, Schlagenhauf P, Barnett ED, Hamer DH; GeoSentinel Global Surveillance Network. Rabies post-exposure prophylaxis started during or after travel: A GeoSentinel analysis. PLoS Negl Trop Dis. 2018 Nov 13;12(11):e0006951. doi: 10.1371/journal.pntd.0006951. eCollection 2018 Nov.

Gregory DJ, Tinline R. Taking the Bite Out of Rabies. Toronto: University of Toronto Press. 2020. doi: 10.3138/9781487519827.

Kong LY, Vincelette J, Laplante G, Duchesne JA, Libman M, Barkati S. Intradermal pre-exposure rabies vaccination in a Canadian travel clinic: 6-year retrospective observational study. CMAJ Open. 2018 Apr 5;6(2):E168-E175. doi: 10.9778/cmajo.20170147.

Rioux Paquette S, Talbot B, Garant D, Mainguy J, Pelletier F. Modelling the dispersal of the two main hosts of the raccoon rabies variant in heterogeneous environments with landscape genetics. Evol Appl 2014 Aug;7(7). doi:10.1111/eva.12161.

Agbata EN, Morton RL, Bisoffi Z, Bottieau E, Greenaway C, Biggs BA, Montero N, Tran A, Rowbotham N, Arevalo-Rodriguez I, Myran DT, Noori T, Alonso-Coello P, Pottie K, Requena-Méndez A. Effectiveness of screening and treatment approaches for Schistosomiasis and Strongyloidiasis in newly-arrived migrants from endemic countries in the EU/EEA: A systematic review. Int J Environ Res Public Health. 2018 Dec 20;16(1). pii: E11. doi: 10.3390/ijerph16010011.

Carabin H, McGarvey ST, Sahlu I, Tarafder MR, Joseph L, Andrade BD, Balolong E, Olveda R. Schistosoma japonicum in Samar, the Philippines: Infection in dogs and rats as a possible risk factor human infection. Epidemiol Infect. 2015; 143(8): 1767-1776. doi: 10.1017/S0950268814002581.

Gautret P, Mockenhaupt FP, von Sonnenburg F, Rothe C, Libman M, Van De Winkel K, Bottieau E, Grobusch MP, Hamer DH, Esposito DH, Parola P, Schlagenhauf P; GeoSentinel Surveillance Network. Local and international implications of schistosomiasis acquired in Corsica, France. Emerg Infect Dis. 2015 Oct;21(10):1865-8. doi: 10.3201/eid2110.150881.

Hassan AS, Nicholas H, Zelt NH, Dilhan J. Perera DJ, Ndao M, Ward BJ. Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model. PLoS Negl Trop Dis. 2019 13(12): e0007490. doi: 10.1371/journal.pntd.0007490.

Kardoush MI, Ward BJ, Ndao M. Serum Carbonic Anhydrase 1 is a biomarker for diagnosis of human Schistosoma mansoni Infection. Am J Trop Med Hyg. 2017 Apr;96(4):842-849. doi: 10.4269/ajtmh.16-0021.

Ricciardi A, Dalton JP, Ndao M. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant. Vaccine. 2015 Jan 3;33(2):346-53. doi: 10.1016/j.vaccine.2014.11.016.

Ricciardi A, Ndao M. Still hope for schistosomiasis vaccine. Hum Vaccin Immunother. 2015;11(10):2504-8. doi: 10.1080/21645515.2015.1059981.

Ricciardi A, Visitsunthorn K, Dalton JP, Ndao M. A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis. BMC Infect Dis. 2016 Mar 5;16:112. doi: 10.1186/s12879-016-1444-z.

Ricciardi A, Zelt NH, Visitsunthorn K, Dalton JP, Ndao M. Immune mechanisms involved in Schistosoma mansoni-Cathepsin B Vaccine induced protection in mice. Front Immunol. 2018 Jul 25;9:1710. doi: 10.3389/fimmu.2018.01710. eCollection 2018.

Shiels J, Cwiklinski K, Alvarado R, Thivierge K, Cotton S, Gonzales Santana B. et al. Schistosoma mansoni immunomodulatory molecule Sm16/SPO-1/SmSLP is a member of the trematode-specific helminth defence molecules (HDMs). PLOS Neglected Tropical Diseases. 2020 14(7): e0008470.

Soentjens P, Cnops L, Huyse T, Yansouni C, De Vos D, Bottieau E, Clerinx J, Van Esbroeck M. Diagnosis and clinical management of Schistosoma haematobium-Schistosoma bovis hybrid infection in a cluster of travelers returning from Mali. Clin Infect Dis. 2016 Dec 15;63(12):1626-1629. doi: 10.1093/cid/ciw493.

Yegorov S, Galiwango RM, Good SV, Mpendo J, Tannich E, Boggild AK, Kiwanuka N, Bagaya BS & Kaul R. Schistosoma mansoni infection and socio-behavioural predictors of HIV risk: a cross-sectional study in women from Uganda. BMC Infectious Diseases. 2018; 18(586). doi: 10.1186/s12879-018-3481-2.

Yegorov S, Joag Y, Galiwango RM, Good SV, Mpendo J, Tannich E, Boggild AK, Kiwanuka N, Bagaya BS & Kaul R. Schistosoma mansoni treatment reduces HIV entry into cervical CD4+ T cells and induces IFN-I pathways. Nat Commun. 2019; 10(2296). doi: 10.1038/s41467-019-09900-9.

Becker S, Liwanag H, Snyder J, Akogun O, Belizario V, Freeman M, Gyorkos T, Imtiaz R, Keiser J, Krolewiecki A, Levecke B, Mwandawiro C, Pullan R, Addiss D, Utzinger J. Toward the 2020 goal of soil-transmitted helmintiasis control and elimination. PLoS Negl Trop Dis. 2018; 12(8) . doi: 10.1371/journal.pntd.0006606.

Blouin B, Casapia M, Joseph L, Gyorkos TW. A longitudinal cohort study of soil-transmitted helminth infections during the second year of life and associations with reduced long-term cognitive and verbal abilities. PLoS Negl Trop Dis. 2018 Jul 27;12(7):e0006688. doi: 10.1371/journal.pntd.0006688.

Blouin B, Casapía M, Joseph L, Kaufman JS, Larson C, Gyorkos TW. The effect of cumulative soil-transmitted helminth infections over time on child development: a 4-year longitudinal cohort study in preschool children using Bayesian methods to adjust for exposure misclassification. Int J Epidemiol. 2018 Aug 1;47(4):1180-1194. doi: 10.1093/ije/dyy142.

Cooper MT, Searing RA, Thompson DM, Bard D, Carabin H, Gonzales C, Zavala C, Woodson K, Naifeh M. Missing the mark? A two time point cohort study estimating intestinal parasite prevalence in informal settlements in Lima, Peru. Glob Pediatr Health. 2017; 4: 1-8. doi 10.1177/2333794X17739190.

Freeman MC, Belizario V, Brooker SJ, Gyorkos TW, Imtiaz R, Krolewiecki A, Lee S, Matendechero SH, Pullan RL, Utzinger J. Challenges and opportunities for control and elimination of soil-transmitted helminth infection beyond 2020. PLOS NTD. 2019; 13(4) e0007201. doi: 10.1371/journal.pntd.0007201.

Gyorkos TW, Montresor A, Belizario V, Biggs B-A, Bradley M, Brooker SJ, Casapia M, Cooper P, Deb S, Gilbert NL, Imtiaz R, Khieu V, Knopp S, Lincetto O, Mofid LS, Mupfasoni D, Vail C, Vercruysse J. The right to deworming: the case for girls and women of reproductive age. PLOS Negl Trop Dis 2018;12(11):e0006740. doi: 10.1371/journal.pntd.0006740.

Gyorkos TW, St-Denis, K. Systematic review of exposure to albendazole or mebendazole during pregnancy and effects on maternal and child outcomes, with particular reference to exposure in the first trimester. Int J Parasitol 2019 May 6. doi: 10.1016/j.ijpara.2019.02.005.

Joseph SA, Casapía M, Lazarte F, Rahme E, Pezo L, Blouin B, Gyorkos TW. The effect of deworming on early childhood development in Peru: a randomized controlled trial. SSM Popul Health. 2015 Nov 21;1:32-39. doi: 10.1016/j.ssmph.2015.10.001.

Joseph SA, Montresor A, Casapía M, Pezo L, Gyorkos TW. Adverse events from a randomized, multi-arm, placebo-controlled trial of Mebendazole in children 12-24 months of age. Am J Trop Med Hyg. 2016 Jul 6;95(1):83-7. doi: 10.4269/ajtmh.15-0816.

Mofid LS, Casapía M, Aguilar E, Silva H, Montresor A, Rahme E, Fraser WD, Marquis GS, Vercruysse J, Allen LH, Blouin B, Razuri H, Pezo L, Gyorkos TW. A double-blind randomized controlled trial of maternal postpartum deworming to improve infant weight gain in the Peruvian Amazon. PLoS Negl Trop Dis. 2017 Jan 5;11(1). doi: 10.1371/journal.pntd.0005098

Mofid LS, Casapía M, Montresor A, Rahme E, Fraser WD, Marquis GS, Vercruysse J, Allen LH, Gyorkos TW. Maternal Deworming Research Study (MADRES) protocol: a double-blind, placebo-controlled randomised trial to determine the effectiveness of deworming in the immediate postpartum period. BMJ Open. 2015 Jun 17;5(6). doi: 10.1136/bmjopen-2015-008560.

Montresor A, Mupfasoni D, Mikhailov A, Mwinzi P, Lucianez A, Jamsheed M, Gasimov E, Warusavithana S, Yajima A, Bisoffi Z, Buonfrate D, Steinmann P, Utzinger J, Levecke B, Vlaminck J, Cools P, Vercruysse J, Cringoli G, Rinaldi L, Blouin B, Gyorkos TW. The global progress of soil-transmitted helminthiases control in 2020 and World Health Organization targets for 2030. PLoS Negl Trop Dis. 2020 14(8): e0008505. doi: 10.1371/journal.pntd.0008505.

Mupfasoni D, Mikhailov A, Mbabazi P, King J, Gyorkos TW, Montresor A. Estimation of the number of women of reproductive age in need of preventive chemotherapy for soil-transmitted helminth infections. PLoS Negl Trop Dis. 2018 Feb 12;12(2). doi: 10.1371/journal.pntd.0006269.

Owada K, Lau CL, Leonardo L, Clements ACA, Yakob L, Nielsen M, Carabin H, Soares Magalhaes RJ. Spatial distribution and populations at risk of A. lumbricoides and T. trichiura co-infections and infection intensity classes: an ecological study. Parasites and Vectors. 2018; 11: 535. doi 10.1186/s13071-018-3107-y.

Soares Magalhaes RJ, Salamat MS, Leonardo L, Gray DJ, Carabin H, Halton K, McManus DP, Williams GM, Rivera P, Saniel O, Hernandez L, Olveda R, Yakob L, McGarvey ST, Clements A. Mapping the risk of soil-transmitted helminthic infections in the Philippines. PLoS Negl Trop Dis 2015; 9(9): e0003915. doi 10.1371/journal.pntd.0003915.

St-Denis K, Blouin B, Rahme E, Casapia M, Montresor A, Mupfasoni D, Mbabazi P, Gyorkos TW. Ruling out early trimester pregnancy when implementing community-based deworming programs. PLoS Negl Trop Dis. 2020; 14(1): e0007901.

Thériault FL, Blouin B, Casapía M, Gyorkos TW. Sustaining a hygiene education intervention to prevent and control geohelminth infections at schools in the Peruvian Amazon. Rev Panam Salud Publica. 2015 Oct;38(4):344-6.

Bhattarai R, Carabin H, Proaño JV, Flores-Rivera J Corona T, Flisser A, Budke CM. Cost of neurocysticercosis patients treated in two referral hospitals in Mexico City, Mexico. Trop Med Int Health. 2015; 20(8): 1108-19. doi: 10.1111/tmi.12497.

Bhattarai R, Carabin H, Proano JV, Flores-Rivera J, Corona T, Flisser A, Leon-Maldonado L, Budke CM. The monetary burden of cysticercosis in Mexico. PLoS Negl Trop Dis. 2019; 13: e0007501.

Bhattarai R, Carabin H, Proano JV, Flores-Rivera H, Corona T, Flisser A, Budke CM. Pre-hospitalization, hospitalization, and post-hospitalization costs of patients with neurcysticercosis treated at the Instituto Nacional de neurologia y neutocirurgia (INNN) in Mexico City, Mexico. Rev Inst Med Trop de Sao Paolo. 2018; 60 : e20. doi: 10.1590/S1678-9946201860020.

Carabin H, Millogo A, Cissé A, Gabriel S, Sahlu I, Dorny P, Bauer C, Ouédraogo J-B, Tarnagda Z, Cowan LD, Ganaba R. Prevalence of and factors associated with human cysticercosis in 60 villages of three provinces of Burkina Faso. PLoS Negl Trop Dis 2015; 9(11): e0004248. doi: 10.1371/journal.pntd.0004248.

Carabin H, Millogo A, Ngowi HA, Bauer C, Dermauw V, Cissé Koné A, Sahlu I, Salvatore AL, Preux P-M, Somé T, Tarnagda Z, Gabriël S, Cissé R, Ouédraogo J-B, Cowan LD, Boncoeur-Martel MP, Dorny P, Ganaba R. Effectiveness of a community-based educational program at reducing the cumulative incidence and prevalence of human Taenia solium cysticercosis in Burkina Faso in 2011-14 (EFECAB): Results of a cluster randomized controlled trial. Lancet Glob Health. 2018; 6(4): e411-25. doi 10.1016/S2214-109X(18)30027-5.

Carabin H, Traoré AA. Taenia solium taeniasis and cysticercosis control and elimination through community-based interventions. Curr Trop Med Rep 2014; 1(4): 181-193. doi 10.1007/s40475-014-0029-4.

Carabin H, Winkler AS, Dorny P. Taenia solium cysticercosis and taeniosis: Achievements from the past 10 years and the way forward. PLoS Negl Trop Dis 2017; 11(4): e0005478. doi 10.1371/journal.pntd.0005478.

Dermauw V, Carabin H, Cissé A, Millogo A, Tarnagda Z, Ganaba R, Noh J, Handali S, Breen K, Cissé R, Preux P-M, Boncoeur-MartelM-P, Winkler A, Tott V, Dorny P, Gabriël S. Evaluating the recombinant T24H EITB assay for the diagnosis of neurocysticercosis in a panel of samples from a large community randomized-control trial in 60 villages in Burkina Faso. Am J Trop Med Hyg 2018; 98(2): 565-9. doi 10.4269/ajtmh.17-0541.

Dermauw V, Carabin H, Ganaba R, Gabriël S, Tarnagda Z, Cissé A, Dorny P, Millogo A. Factors associated with the 18-month cumulative incidence of seroconversion of active infection with Taenia solium cysticercosis: A cohort study among residents of 60 villages in Burkina Faso. Am Journal of Trop Med Hyg. 2018; 99(4): 1018-27. doi 10.4269/ajtmh.18-0294.

Dermauw V, Ganaba R, Cissé A, Ouédraogo B, Millogo A, Tarnagda Z, Van Hul A, Gabriël S, Carabin H, Dorny P. Taenia hydatigena in pigs in Burkina Faso: A cross-sectional abattoir study. Vet Parasitol 2016; 230: 9-13. doi 10.1016/j.vetpar.2016.10.022.

Dickey M, Carabin H, John R, Xiaonong Z. Program evaluation of a sanitation marketing campaign among the Bai in China: A strategy for cysticercosis reduction. Social Marketing Quarterly 2015; 21(1): 37-50. doi: 10.1177/1524500415569548.

Dickey M, John R, Carabin H, Xiao-Nong Z. Focus group discussions among the Bai in China to Inform a social marketing campaign for sanitation promotion. Journal of Water, Sanitation and Hygiene for Development 2016; 6(1): 121-131. doi 10.2166/washdev.2016.064.

Hanas JS, Hocker JR, Ramajayam G, Prabhakaran V, Rajshekhar, omen A, Manoj JJ, Anderson MP, Drevets DA, Carabin H. Distinguishing neurocysticercosis epilepsy from epilepsy of unknown etiology using a minimal serum mass profiling plaform. Exp Parasitol 2018; 192: 98-107. doi 10.1016/j.exppara.2018.07.015.

Mwidunda SA, Carabin H, Matuja WBM, Winkler AS, Ngowi HA. A school based cluster randomised health education intervention trial for improving knowledge and attitudes related to Taenia solium cysticercosis and taeniasis in Mbulu district, northern Tanzania. PLoS One 2015; 10: e0118541. doi 10.1371/journal.pone.0118541.

Ngowi HA, Ozbolt I, Millogo A, Dermauw V, Somé T, Spicer PG, Jervis LL, Ganaba R, Carabin H. Development of a health education intervention strategy using an implementation research method to control taeniasis and cysticercosis in Burkina Faso. Infect Dis Poverty. 2017; 6: 95. doi 10.1186/s40249-017-0308-0.

Prabhakaran V, Drevets DA, Ramajayam G, Babu JJ, Anderson MP, Hanas J, Rajshekhar V, Oommen A, Carabin H. Comparison of monocyte gene expression among patients with neurocysticercosis-associated epilepsy, idiopathic epilepsy and idiopathic headaches India. PLoS Negl Trop Dis. 2017; 11(6): e0005664. doi 10.1371/journal.pntd.0005664.

Sahlu I, Carabin H, Ganaba R, Preux P-M, Bauer Koné Cissé A, Tarnagda Z, Gabriël S, Dermauw V, Dorny P, Bauer C, Millogo A. Estimating the misclassification-error adjusted association between active cysticercosis and the prevalence of epilepsy and severe chronic headaches in 60 villages of rural Burkina Faso. PLoS Negl Trop Dis. 2019; 13: e0007101.

Schmidt V, Kositz C, Herbinger K-H, Carabin H, Ngowi B, Naman E, Wilkins PP, Noh J, Matuja W, Winkler AS. Association between Taenia solium infection and HIV/AIDS in northern Tanzania: a matched cross sectional-study. Infect Dis Poverty 2016; 5: 111. doi 10.1186/s40249-016-0209-7.

White AC Jr, O’Neal S, Winkler A, Abraham A, Carabin H. The data are inadequate to assess safety and efficacy of mass chemotherapy for Taenia solium taeniasis. PLOS Negl Trop Dis. 2020; 14(7): e0008294. doi: 10.1371/journal.pntd.0008294.